Prevalence of prescribing of different anti-diabetic medications among all patients with type 2 diabetes on treatment. *Other=Sum of prevalence of Acarbose,

Slides:



Advertisements
Similar presentations
Associations between OHS/OKS and hospital readmission costs >12 months after THR. Costs are measured in 2014 pound sterling (£). Associations between OHS/OKS.
Advertisements

Choosing glucose-lowering medication in those with established ASCVD, HF, and CKD. CV, cardiovascular; DPP-4i, dipeptidyl peptidase 4 inhibitor; GLP-1.
(A) Participation rates of primary care paediatricians per region in Bavaria (blue) and the mean number of children screened per primary care paediatrician.
Number of local authorities (LAs) commissioning each service directly or indirectly (n=148) (*Flu vaccination data excludes the service commissioned across.
Study sample selection process.
Mean expense per year on courses and conferences that trainees have not been reimbursed. Mean expense per year on courses and conferences that trainees.
Daily contribution (%) of sodium and potassium from major food groups among participants aged 8–12 years (n=517), which includes major food groups provided.
Defining study follow-up periods—index date (entry into cohort) and breaks in MSP registration. †End of follow-up due to earliest of: active TB diagnosis,
Bar charts comparing the results of ePROMs between patients who found the scores inadequately assessed their symptoms against all other patients leaving.
Incidence trends for each human papillomavirus-related cancer-type among women in Norway 1953–2015. Incidence trends for each human papillomavirus-related.
Toxicity spectra and rankings in the subgroup analysis based on each specific grade 1-5 adverse event and cancer type. Toxicity spectra and rankings in.
Scatter graph showing total work time equivalent of all specialist palliative care practitioners commissioned by the Clinical Commissioning Group (CCG)
(A) Indirectly age-sex-deprivation-ethnicity standardised procedure ratios for combined eye injection procedures (OPCS-4: C794 and C893) by CCG in England,
DSM-IV delirium prevalence, including the estimated delirium prevalence in the 31 patients that did not undergo delirium assessment following initial screening.
Scatter graph showing the total number of specialist palliative care beds commissioned compared with the estimated number of people with palliative care.
Estimated probability of successful quitting (quit attempt of longer than 1 year) by quit attempt number in the Ontario Tobacco Survey. Estimated probability.
Trending patterns of life expectancy by sex, SES quintile and remoteness, NSW, 2001–2012. Trending patterns of life expectancy by sex, SES quintile and.
Differences in life expectancy by SES, sex and remoteness, NSW, 2001 and Differences in life expectancy by SES, sex and remoteness, NSW, 2001 and.
Estimated changes in body mass index (difference in BMI) after October 2010 among nursery schoolchildren born between 2 April 2006 and 1 April 2007 in.
A schematic representation of the possible pairwise comparisons of adherence and persistence between different medication classes. A schematic representation.
A, B, C, D show outcome results for individual symptoms using GSRS-IBS scoring system and mean symptom severity scores before and after IBS dietetic management.
Trends in the relative contribution of each second-line diabetes medication class, by quarter, as a percent of all second-line prescribing, 2011–2015.
Gender differences in diabetes prevalence in 2009 in the general Portuguese population patients and in patients with CAP. Diabetes prevalence is higher.
Kaplan-Meier plot of incident CVD according to the treatment group over a 4-year period following intensification of diabetes therapy. Kaplan-Meier plot.
Decline in the risk of carotid occlusion with more intensive medical therapy. Decline in the risk of carotid occlusion with more intensive medical therapy.
Details of the most commonly nominated conditions for the most commonly nominated small animal (a) and large animal (b) species as outlined by 3982 veterinary.
Quality Improvement (A) (B) % Smokers Receiving Medication
1-year and 5-year survival rates by cancer type, stage and group, England, up to 2011– year and 5-year survival rates by cancer type, stage and.
by Melanie J Calvert, Richard J McManus, and Nick Freemantle
CANVAS programe subanalyses HR (95%CI): 0.65 ( ) ( ) ( ) ( )
Keratinocyte growth factor (KGF) versus no KGF for the reduction of severe oral mucositis in patients receiving treatment for cancer or undergoing haematopoietic.
Governance and information centre requirements prior to application approval. s251, section 251 of the NHS 2006 Act; ONS, Office for National Statistics;
Three-year cumulative incidence of diagnosed autism among boys aged 2–4 years, in birth cohorts. Three-year cumulative incidence of diagnosed autism among.
Distribution of total possible savings (y-axis), showing how much total saving there would be if only those over £x per practice per month (x-axis) were.
Changes of (A) glycated haemoglobin (HbA1c) and (B) estimated glomerular filtration rate (eGFR) in the blood test at baseline and at 3, 6 and 12 months.
Number of patients who would have benefitted from addition of ACE inhibitor (ACEi), beta blockers (BB) or optimal therapy (one or both of ACEi and BB)
Proportions of discharge diagnoses or death following first readmission/death within 30 or 180 days after initial discharge, according to the presence.
Knowledge gaps in key risk factor numbers
Scatter graph showing total work time equivalent of all specialist palliative care practitioners commissioned by the Clinical Commissioning Group (CCG)
Affected and unaffected prefectures in northeast Japan
Box and whisker plot showing the estimated budget per person with palliative care needs (using the estimation that 0.75% of the population has palliative.
Difference in cumulative revision of knee constructs compared with a contemporary benchmark at 7 years in men aged between 55 years and 75 years, using.
Number of patients treated at clinics that followed up fewer than 10 patients (2013–2016) or 20 patients (2012) and proportion of patients followed up.
Cryotherapy versus no cryotherapy for the reduction of severe oral mucositis in patients receiving treatment for cancer or undergoing haematopoietic stem.
Prevalence of prescribing of different anti-diabetic medications as add-on therapy in patients with type 2 diabetes on metformin. *Other=Sum of prevalence.
Factors associated with preparedness competency of public health inspectors from the qualitative analysis, which are grouped into three levels according.
Cumulative incidence of pterygium among smokers and never-smokers between 1 January 2004 and 31 December Cumulative incidence of pterygium among.
by Marion Murphy, Stephen Byrne, and Colin P Bradley
Time trends in the number of monthly admissions throughout the study period. Time trends in the number of monthly admissions throughout the study period.
Bubble plot with a fitted meta-regression line of the log prevalence of commercial pad use by adolescent girls over time, 104 studies in India published.
Fig 4 Population level predicted proportions of cutaneous melanocytic biopsy interpretations that would be verified by the consensus reference panel or.
Correlation between change in blood pressure (BP) and a rapid annual decline in kidney function (≥3 mL/min/1.73 m2/year) (logistic regression) (n=7283).
Absolute survival probability (per cent who have not quit successfully) of reported quit attempts of longer than 1 year during the first 18 months of observation.
Showing (A) the reported activity of community midwifery teams in recommending and providing seasonal influenza vaccination to pregnant women and (B) the.
Eye position of positional nystagmus in the right-ear-down and left-ear-down head positions in patients with horizontal canal type of benign paroxysmal.
Elevated blood glucose vs time.
Prospective associations of beverage consumption with incident type 2 diabetes: random effects meta-analysis. *Unadjusted for adiposity. †Adjusted for.
Status of tapering in the first year of follow-up.
Predicted survival curves for hip replacements for two male and two female hypothetical individuals with different levels of blood cobalt at 2 and 5 µg/l.
Themes of Positionality, Core Concepts, Social/Environmental Factors, and Paradigms/Theories/Models. *Indicates answers specifically from the third open-ended.
Distribution of product medicinal products without commercial interest (MPWCI) presentations (original list) studied due to the age of the marketing authorisation.
Representativeness of linked cancer registry and dispensed prescription data as compared with cancer registry data alone, by key patient and tumour characteristics.
Health states and movement between health states in Markov model.
Prevalence of diabetes (diagnosed by glycated haemoglobin (HbA1c) ≥6
Estimated relative change in price of fruit and vegetable subgroups under each modelled Brexit scenario. Estimated relative change in price of fruit and.
Average change in blood pressure (BP) from recruitment to 6-month postrecruitment in intervention and control patients >50 years included due to having.
Standardised patient wearing the obesity simulation suit used in the present study to represent a patient with type 2 diabetes and grade 2 obesity. The.
Number of hospital presentations for self-harm in Derby from 2003 to 2012 (inclusive) based on Multicentre Study data, Hospital Episode Statistics (HES)
Forest plot of the prevalence rates of acne according to region.
Kaplan–Meier plot of proportion of persons convicted (excluding traffic offenses) for the first time in the background population (thin line) and in men.
Presentation transcript:

Prevalence of prescribing of different anti-diabetic medications among all patients with type 2 diabetes on treatment. *Other=Sum of prevalence of Acarbose, GLP-1 analogues, Meglitinides and SGLT-2 inhibitors. **For detailed values of point estimates and CIs, please consult online supplementary appendix 3. Prevalence of prescribing of different anti-diabetic medications among all patients with type 2 diabetes on treatment. *Other=Sum of prevalence of Acarbose, GLP-1 analogues, Meglitinides and SGLT-2 inhibitors. **For detailed values of point estimates and CIs, please consult online supplementary appendix 3. Manuj Sharma et al. BMJ Open 2016;6:e010210 ©2016 by British Medical Journal Publishing Group